Trends in clinical validation and usage of US Food and Drug Administration-cleared artificial intelligence algorithms for medical imaging.

Journal: Clinical radiology
Published Date:

Abstract

AIM: To examine the current landscape of US Food and Drug Administration (FDA)-approved artificial intelligence (AI) medical imaging devices and identify trends in clinical validation strategy.

Authors

  • M Khunte
    Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
  • A Chae
    Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • R Wang
    School of Forensic Medicine, Kunming Medical University, Kunming 650500, China.
  • R Jain
    Departments of Radiology and Neurosurgery (R.J.), New York University, New York, New York.
  • Y Sun
    Department of Chemistry, The University of Massachusetts, Lowell, MA, USA.
  • J R Sollee
    Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
  • Z Jiao
    Department of Diagnostic Imaging, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.
  • H X Bai
    Department of Diagnostic Imaging (J.B., H.X.B.), Rhode Island Hospital.